Clecell
Business Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
172 돌마로 H6107, Seongnam, Gyeonggi-do, So...Website
www.clecell.co.krRevenue
$12 MillionIndustry
About Clecell
Clecell Org Chart
Is Clecell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Clecell is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Clecell
Product Launch: Get notified when Clecell launches new products
Earning: See what the market has to say on Clecell recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Clecell has recently received funding, and reach out quickly before it becomes old news!
Click to see if Clecell had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Clecell has new funding data
Clecell, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Clecell is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Clecell is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Clecell.
Clecell Tech Stack
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Clecell
클리셀 is a BIO platform company that creates a new future in the fields of tissue engineering and regenerative medicine based on advanced 3D bioprinting technology. The company focuses on research and development to drive innovation in life sciences, healthcare, and regenerative medicine, aiming for a sustainable future. Their research team has devel... Read More